NYSE:MNK - Mallinckrodt Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $1.75
  • Forecasted Upside: 445.17 %
  • Number of Analysts: 5
  • Breakdown:
  • 1 Sell Ratings
  • 4 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.32
+0.30 (1.20%)
Get New Mallinckrodt Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MNK and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MNK

Analyst Price Target is $1.75
▲ +445.17% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Mallinckrodt in the last 3 months. The average price target is $1.75, with a high forecast of $2.00 and a low forecast of $1.50. The average price target represents a 445.17% upside from the last price of $0.32.

This chart shows the closing price for MNK for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 5 contributing investment analysts is to hold stock in Mallinckrodt. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 3 buy ratings
  • 9 hold ratings
  • 2 sell ratings
1/30/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 10 hold ratings
  • 4 sell ratings
4/29/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 8 hold ratings
  • 3 sell ratings
7/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 6 hold ratings
  • 4 sell ratings
10/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 4 sell ratings
1/24/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 3 sell ratings
4/24/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 1 sell ratings
6/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 1 sell ratings
7/23/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/15/2020Raymond JamesReiterated RatingHoldLow
9/14/2020SVB LeerinkLower Price TargetMarket Perform$2.00 ➝ $1.50High
8/5/2020BarclaysReiterated RatingHoldHigh
8/5/2020BMO Capital MarketsLower Price TargetMarket Perform$4.00 ➝ $2.00High
8/4/2020Piper SandlerDowngradeNeutral ➝ UnderweightHigh
5/19/2020JPMorgan Chase & Co.DowngradeNeutral ➝ UnderweightMedium
5/6/2020SVB LeerinkBoost Price TargetMarket Perform$2.00 ➝ $3.00High
4/24/2020CitigroupInitiated CoverageSellLow
4/2/2020BarclaysLower Price TargetEqual Weight$5.00 ➝ $3.00High
4/1/2020CfraLower Price TargetHold$6.00 ➝ $4.00Low
2/26/2020Bank of AmericaBoost Price TargetUnderperform$3.00Low
1/22/2020Wells Fargo & CompanyReiterated RatingHoldHigh
12/9/2019Wells Fargo & CompanyReiterated RatingHoldMedium
10/9/2019Wells Fargo & CompanyReiterated RatingHoldHigh
9/10/2019BarclaysSet Price TargetHold$5.00N/A
9/9/2019Stifel NicolausLower Price TargetHold$20.00 ➝ $8.00High
9/6/2019Jefferies Financial GroupSet Price TargetHold$2.00High
9/6/2019SVB LeerinkSet Price TargetHold$2.00High
9/5/2019BMO Capital MarketsReiterated RatingOutperform ➝ Market PerformHigh
9/4/2019BMO Capital MarketsDowngradeOutperform ➝ Hold$3.00Low
8/28/2019BarclaysLower Price TargetEqual Weight$7.00 ➝ $5.00Low
8/12/2019SunTrust BanksLower Price TargetHold ➝ Positive$7.00High
8/9/2019Morgan StanleySet Price TargetHold$5.00Low
8/7/2019Stifel NicolausSet Price TargetHold$20.00High
8/7/2019BMO Capital MarketsSet Price TargetBuy$19.00High
7/12/2019Cantor FitzgeraldSet Price TargetBuy$18.00Medium
7/11/2019Jefferies Financial GroupLower Price TargetHold ➝ Reduce$15.00 ➝ $10.00Low
6/14/2019Canaccord GenuityLower Price TargetBuy$37.00 ➝ $22.00High
6/12/2019Cantor FitzgeraldLower Price TargetOverweight$42.00 ➝ $18.00Low
6/11/2019BarclaysInitiated CoverageEqual Weight ➝ Equal Weight$11.00Low
6/6/2019Wells Fargo & CompanyLower Price TargetMarket Perform$25.00 ➝ $11.00Low
5/30/2019Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$39.00 ➝ $9.00High
5/28/2019MizuhoLower Price TargetNeutral$22.00 ➝ $13.00Low
5/24/2019JPMorgan Chase & Co.Lower Price TargetNeutral$22.00 ➝ $11.00High
5/22/2019BMO Capital MarketsReiterated RatingOutperform$23.00High
5/22/2019Jefferies Financial GroupDowngradeBuy ➝ Hold$25.00 ➝ $15.00High
5/21/2019Berenberg BankReiterated RatingSell$10.00 ➝ $5.00High
5/16/2019MizuhoLower Price TargetNeutral$25.00 ➝ $22.00Medium
5/14/2019SunTrust BanksSet Price TargetHold$20.00Low
3/19/2019SunTrust BanksInitiated CoverageHold ➝ Hold$23.00Medium
3/18/2019Canaccord GenuitySet Price TargetBuy$40.00Medium
2/28/2019Morgan StanleySet Price TargetHold$32.00Low
2/28/2019MizuhoBoost Price TargetNeutral$26.00Low
12/31/2018B. RileyLower Price TargetNeutral$21.00Low
12/17/2018MizuhoReiterated RatingNeutral ➝ NeutralHigh
12/7/2018Wells Fargo & CompanySet Price TargetHold$27.00Medium
12/7/2018Piper Jaffray CompaniesSet Price TargetBuy$39.00High
11/25/2018Canaccord GenuitySet Price TargetBuy$40.00High
11/19/2018Canaccord GenuityUpgradeHold ➝ Buy$34.00 ➝ $40.00Medium
11/13/2018MizuhoBoost Price TargetNeutral$29.00Low
11/7/2018Berenberg BankSet Price TargetSell$23.00Medium
11/6/2018Wells Fargo & CompanySet Price TargetHold$27.00High
11/6/2018MizuhoReiterated RatingHold$27.00High
10/8/2018Wells Fargo & CompanySet Price TargetHold$24.00Low
9/14/2018Berenberg BankInitiated CoverageSell$25.00High
9/11/2018The Goldman Sachs GroupDowngradeNeutral ➝ Sell$27.00 ➝ $28.00Medium
8/24/2018B. RileyBoost Price TargetNeutral ➝ Neutral$20.00 ➝ $37.00Medium
8/22/2018Wells Fargo & CompanyReiterated RatingHoldLow
8/19/2018Canaccord GenuitySet Price TargetHold$34.00High
8/17/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$14.00 ➝ $35.00High
8/13/2018Canaccord GenuityReiterated RatingHold$22.00Low
8/13/2018SunTrust BanksBoost Price TargetHold ➝ Positive$32.00Low
8/8/2018Wells Fargo & CompanySet Price TargetMarket Perform ➝ Market Perform$21.00 ➝ $30.00High
8/8/2018SVB LeerinkBoost Price TargetMarket Perform$12.00 ➝ $27.00High
8/8/2018BarclaysBoost Price TargetUnderweight ➝ Underweight$12.00 ➝ $20.00High
8/8/2018Stifel NicolausBoost Price TargetHold ➝ Hold$18.00 ➝ $30.00Medium
8/8/2018Raymond JamesDowngradeOutperform ➝ Market Perform$58.00Medium
8/8/2018Piper Jaffray CompaniesReiterated RatingBuy$39.00Low
8/7/2018BMO Capital MarketsReiterated RatingOutperform$37.00Low
8/7/2018Cantor FitzgeraldReiterated RatingBuy$42.00High
7/19/2018Canaccord GenuityBoost Price TargetHold ➝ Hold$14.00 ➝ $22.00Low
7/9/2018Wells Fargo & CompanyBoost Price TargetMarket Perform ➝ Market Perform$15.00 ➝ $21.00High
6/28/2018B. RileyBoost Price TargetNeutral ➝ Neutral$15.00 ➝ $20.00Medium
6/19/2018SunTrust BanksBoost Price TargetHold$21.00Low
6/18/2018Stifel NicolausBoost Price TargetHold ➝ Hold$15.00 ➝ $18.00Low
5/15/2018OppenheimerReiterated RatingHoldLow
5/9/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$27.00 ➝ $14.00High
5/9/2018BarclaysSet Price TargetUnderweight ➝ Underweight$20.00 ➝ $12.00High
5/8/2018Canaccord GenuitySet Price TargetHold$14.00High
5/8/2018Cantor FitzgeraldReiterated RatingBuy$42.00Medium
5/4/2018Wells Fargo & CompanySet Price TargetHold$17.50 ➝ $15.00Low
5/3/2018MizuhoReiterated RatingHold$15.00Medium
5/2/2018B. RileyInitiated CoverageNeutral ➝ Neutral$15.00 ➝ $15.00Low
4/30/2018Cantor FitzgeraldSet Price TargetBuy$42.00Low
4/26/2018MizuhoReiterated RatingHold$15.00Low
4/23/2018SVB LeerinkLower Price TargetMarket PerformLow
4/20/2018MizuhoReiterated RatingHold$15.00Low
4/12/2018Stifel NicolausDowngradeBuy ➝ Hold$50.00High
4/12/2018Wells Fargo & CompanyReiterated RatingHoldHigh
4/11/2018SunTrust BanksInitiated CoverageHold$15.00High
4/2/2018Cantor FitzgeraldSet Price TargetBuy$42.00High
3/16/2018Wells Fargo & CompanySet Price TargetHold$18.00High
3/9/2018MizuhoReiterated RatingNeutral ➝ Neutral$21.00 ➝ $16.00Medium
3/6/2018Canaccord GenuitySet Price TargetHold$20.00High
2/27/2018OppenheimerReiterated RatingHoldHigh
2/27/2018Cantor FitzgeraldSet Price TargetBuy$42.00High
2/2/2018BarclaysDowngradeEqual Weight ➝ Underweight$23.00 ➝ $20.00Medium
1/9/2018MizuhoReiterated RatingNeutral ➝ Neutral$22.00 ➝ $21.00N/A
1/8/2018Cantor FitzgeraldSet Price TargetBuy$42.00Medium
1/7/2018Canaccord GenuitySet Price TargetHold$24.00Medium
1/2/2018SVB LeerinkInitiated CoverageMkt Perform ➝ Market Perform$26.00Medium
1/1/2018Wells Fargo & CompanyReiterated RatingHoldHigh
1/1/2018The Goldman Sachs GroupReiterated RatingHoldHigh
1/1/2018Canaccord GenuitySet Price TargetHold$24.00High
1/1/2018Cantor FitzgeraldSet Price TargetBuy$42.00High
12/26/2017Cantor FitzgeraldSet Price TargetBuy$42.00Low
12/26/2017The Goldman Sachs GroupReiterated RatingHoldLow
12/26/2017Canaccord GenuitySet Price TargetHold$24.00Low
12/26/2017Wells Fargo & CompanyReiterated RatingHoldLow
12/12/2017BarclaysSet Price TargetHold$23.00High
11/26/2017UBS GroupDowngradeBuy ➝ Neutral$70.00 ➝ $24.00Medium
11/22/2017OppenheimerReiterated RatingOutperform ➝ Market PerformN/A
11/14/2017Canaccord GenuitySet Price TargetHold$24.00N/A
11/13/2017UBS GroupDowngradeBuy ➝ Neutral$24.00N/A
11/8/2017Canaccord GenuityLower Price TargetBuy$38.00 ➝ $24.00N/A
11/8/2017Stifel NicolausLower Price TargetBuy$70.00 ➝ $50.00N/A
11/8/2017Morgan StanleyLower Price TargetEqual Weight$40.00 ➝ $27.00N/A
11/8/2017BMO Capital MarketsLower Price TargetOutperform$38.00N/A
11/8/2017The Goldman Sachs GroupDowngradeBuy ➝ Neutral$55.00N/A
11/8/2017Jefferies Financial GroupInitiated CoverageMarket Perform ➝ Buy$60.00 ➝ $30.00N/A
11/8/2017BarclaysDowngradeOverweight ➝ Equal Weight$65.00 ➝ $23.00N/A
11/8/2017Wells Fargo & CompanyDowngradeOutperform ➝ Market PerformN/A
11/7/2017CitigroupDowngradeBuy ➝ Hold$44.00 ➝ $28.00N/A
11/7/2017Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$44.00 ➝ $28.00N/A
11/2/2017Cantor FitzgeraldReiterated RatingBuy$52.00N/A
10/21/2017Piper Jaffray CompaniesSet Price TargetBuy$67.00N/A
10/15/2017MizuhoReiterated RatingHold$40.00N/A
10/6/2017Stifel NicolausReiterated RatingBuyN/A
10/6/2017Jefferies Financial GroupReiterated RatingBuy$60.00N/A
10/6/2017UBS GroupSet Price TargetBuy$70.00N/A
10/5/2017Piper Jaffray CompaniesReiterated RatingBuy$67.00N/A
10/4/2017Canaccord GenuityDowngradeBuy ➝ Hold$77.00 ➝ $40.00N/A
10/2/2017Cantor FitzgeraldSet Price TargetBuy$52.00Medium
9/28/2017The Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$55.00Medium
9/19/2017OppenheimerLower Price Target$70.00 ➝ $48.00Low
9/15/2017Piper Jaffray CompaniesReiterated RatingBuy$67.00Low
9/14/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$56.00 ➝ $45.00Low
9/14/2017CitigroupLower Price TargetReduce ➝ Buy$45.00Low
9/13/2017MizuhoDowngradeBuy ➝ Neutral$70.00 ➝ $40.00Medium
9/6/2017UBS GroupReiterated RatingBuy$70.00Low
9/6/2017Stifel NicolausReiterated RatingBuy$85.00Low
9/6/2017MizuhoReiterated RatingBuy$70.00Low
9/6/2017Morgan StanleyDowngradeOverweight ➝ Equal Weight$65.00 ➝ $40.00Low
9/5/2017Cantor FitzgeraldReiterated RatingBuy$52.00Low
8/25/2017Jefferies Financial GroupLower Price TargetBuy$70.00 ➝ $60.00Low
8/9/2017MizuhoReiterated RatingBuy$73.00 ➝ $70.00Medium
8/9/2017BMO Capital MarketsReiterated RatingOutperform$69.00 ➝ $65.00Low
8/9/2017Raymond JamesLower Price TargetOutperform$65.00 ➝ $58.00Low
8/9/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy$68.00 ➝ $56.00Low
8/9/2017UBS GroupSet Price TargetBuy$70.00High
8/8/2017Canaccord GenuitySet Price TargetBuy$87.00High
8/8/2017OppenheimerSet Price TargetBuy$70.00High
8/7/2017Piper Jaffray CompaniesSet Price TargetBuy$85.00Medium
8/3/2017Jefferies Financial GroupReiterated RatingBuy$70.00Medium
7/28/2017BMO Capital MarketsReiterated RatingBuy$69.00Low
7/28/2017OppenheimerSet Price TargetBuy$70.00Low
7/17/2017Canaccord GenuitySet Price TargetBuy$87.00Medium
7/16/2017Piper Jaffray CompaniesSet Price TargetBuy$85.00Medium
6/29/2017UBS GroupReiterated RatingBuy$100.00 ➝ $70.00N/A
6/21/2017Wells Fargo & CompanyReiterated RatingOutperform$83.50High
6/20/2017Jefferies Financial GroupReiterated RatingBuy$70.00High
6/16/2017Cantor FitzgeraldInitiated CoverageOverweight ➝ Overweight$52.00Low
5/31/2017Morgan StanleySet Price TargetBuy$65.00Low
5/31/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy$68.00Low
5/31/2017MizuhoReiterated RatingBuy$73.00Low
5/31/2017Jefferies Financial GroupReiterated RatingBuy$70.00Low
5/24/2017UBS GroupSet Price TargetBuy$70.00N/A
5/10/2017BMO Capital MarketsLower Price TargetOutperform$79.00 ➝ $69.00Medium
5/9/2017Canaccord GenuityLower Price TargetBuy ➝ Buy$91.00 ➝ $87.00Medium
4/21/2017Jefferies Financial GroupReiterated RatingBuy$70.00High
4/1/2017GuggenheimSet Price TargetBuy$98.00Low
3/20/2017SVB LeerinkReiterated RatingOutperformLow
3/13/2017Jefferies Financial GroupDowngradeBuy$95.00 ➝ $70.00Low
2/22/2017UBS GroupSet Price TargetBuy$77.00N/A
2/21/2017Canaccord GenuityInitiated CoverageBuy ➝ Buy$91.00N/A
2/8/2017UBS GroupSet Price TargetBuy$77.00N/A
2/8/2017SVB LeerinkSet Price TargetBuy$60.00N/A
2/8/2017Piper Jaffray CompaniesLower Price TargetOverweight$108.00 ➝ $83.00N/A
2/3/2017MizuhoLower Price TargetBuy$85.00 ➝ $69.00N/A
1/25/2017JPMorgan Chase & Co.Set Price TargetHold$78.00N/A
1/19/2017OppenheimerSet Price TargetBuy$72.00N/A
1/19/2017Wells Fargo & CompanyReiterated RatingBuyN/A
1/19/2017GuggenheimSet Price TargetBuy$98.00N/A
1/19/2017MizuhoReiterated RatingBuy$85.00N/A
1/8/2017MizuhoReiterated RatingBuy$85.00N/A
12/29/2016GuggenheimReiterated RatingBuy$98.00N/A
12/20/2016OppenheimerReiterated RatingOutperformN/A
12/9/2016MizuhoReiterated RatingBuy$87.00N/A
12/7/2016OppenheimerReiterated RatingOutperformN/A
12/6/2016OppenheimerSet Price TargetBuy$115.00 ➝ $72.00N/A
12/1/2016MizuhoLower Price TargetBuy$87.00 ➝ $85.00N/A
11/30/2016SVB LeerinkSet Price TargetBuy$70.00N/A
11/30/2016JPMorgan Chase & Co.Lower Price TargetNeutral$85.00 ➝ $78.00N/A
11/30/2016Deutsche Bank AktiengesellschaftLower Price TargetBuy$78.00 ➝ $73.00N/A
11/29/2016BMO Capital MarketsReiterated RatingOutperform$92.00N/A
11/25/2016MizuhoLower Price TargetBuy$87.00 ➝ $85.00N/A
11/21/2016Deutsche Bank AktiengesellschaftReiterated RatingBuy$78.00N/A
11/21/2016UBS GroupSet Price TargetBuy$92.00N/A
11/19/2016SVB LeerinkReiterated RatingOutperform$92.00N/A
11/19/2016MizuhoReiterated RatingBuy$89.00 ➝ $87.00N/A
11/18/2016Raymond JamesInitiated CoverageOutperform$72.00N/A
10/21/2016Wells Fargo & CompanyReiterated RatingOutperform$88.50 ➝ $83.50N/A
10/18/2016Deutsche Bank AktiengesellschaftReiterated RatingBuy$82.00 ➝ $78.00N/A
9/29/2016MizuhoLower Price TargetBuy$91.00 ➝ $89.00N/A
9/21/2016Morgan StanleyReiterated RatingBuy$82.00N/A
9/16/2016SVB LeerinkReiterated RatingOutperform$91.00 ➝ $92.00N/A
9/8/2016Morgan StanleySet Price TargetBuy$82.00N/A
9/7/2016Piper Jaffray CompaniesReiterated RatingOverweight$112.00 ➝ $105.00N/A
8/31/2016Deutsche Bank AktiengesellschaftLower Price TargetBuy$87.00 ➝ $84.00N/A
8/29/2016MizuhoReiterated RatingBuy$91.00N/A
8/26/2016The Goldman Sachs GroupReiterated RatingNeutral$83.00N/A
8/25/2016BMO Capital MarketsReiterated RatingPositive ➝ Outperform$93.00N/A
8/25/2016BarclaysReiterated RatingOverweight$88.00N/A
8/24/2016Piper Jaffray CompaniesBoost Price TargetOverweight$103.00 ➝ $112.00N/A
8/13/2016MizuhoReiterated RatingBuy$91.00N/A
8/12/2016Stifel NicolausInitiated CoverageBuy$95.00N/A
8/4/2016Jefferies Financial GroupReiterated RatingBuy$85.00 ➝ $95.00N/A
8/3/2016Piper Jaffray CompaniesSet Price TargetBuy$102.00 ➝ $103.00N/A
8/3/2016JPMorgan Chase & Co.Set Price TargetHold$85.00N/A
8/3/2016BarclaysBoost Price TargetOverweight$75.00 ➝ $88.00N/A
8/3/2016GuggenheimReiterated RatingBuy$98.00N/A
8/3/2016UBS GroupBoost Price TargetBuy$85.00 ➝ $92.00N/A
8/3/2016SVB LeerinkSet Price TargetBuy$84.00 ➝ $91.00N/A
8/3/2016MizuhoBoost Price TargetBuy$83.00 ➝ $91.00N/A
(Data available from 7/24/2016 forward)
Mallinckrodt logo
Mallinckrodt Plc is a global specialty pharmaceuticals company. It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical products and medical imaging agents. It operates through the Specialty Brands and Specialty Generics segments. The Specialty Brands segment includes branded medicines. The Specialty Generics segment relates to specialty generic drugs, active pharmaceutical ingredients, as well as external manufacturing. The company was founded by Gustavo Mallinckrodt, Otto Mallinckrodt and Edward Mallinckrodt in 1867 and is headquartered in Blanchardstown, Dublin.
Read More

Today's Range

Now: $0.32
Low: $0.32
High: $0.34

50 Day Range

MA: $0.34
Low: $0.14
High: $0.75

52 Week Range

Now: $0.32
Low: $0.75
High: $6.42

Volume

122,520 shs

Average Volume

6,488,121 shs

Market Capitalization

$27.15 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.06

Frequently Asked Questions

What sell-side analysts currently cover shares of Mallinckrodt?

The following sell-side analysts have issued reports on Mallinckrodt in the last twelve months: Barclays PLC, BMO Capital Markets, Piper Sandler, Raymond James, and SVB Leerink LLC.
View the latest analyst ratings for MNK.

What is the current price target for Mallinckrodt?

2 Wall Street analysts have set twelve-month price targets for Mallinckrodt in the last year. Their average twelve-month price target is $1.75, suggesting a possible upside of 445.2%. BMO Capital Markets has the highest price target set, predicting MNK will reach $2.00 in the next twelve months. SVB Leerink LLC has the lowest price target set, forecasting a price of $1.50 for Mallinckrodt in the next year.
View the latest price targets for MNK.

What is the current consensus analyst rating for Mallinckrodt?

Mallinckrodt currently has 1 sell rating and 4 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in MNK, but not buy more shares or sell existing shares.
View the latest ratings for MNK.

What other companies compete with Mallinckrodt?

How do I contact Mallinckrodt's investor relations team?

Mallinckrodt's physical mailing address is COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH BLANCHARDSTOWN, DUBLIN 15 L2, D15. The company's listed phone number is (531) 696-0000 and its investor relations email address is [email protected] The official website for Mallinckrodt is www.mallinckrodt.com.